N/A
Manufactured by Atlantis Consumer Healthcare, Inc.
46,972 FDA adverse event reports analyzed
Last updated: 2026-04-14
STANDARDIZED SENNA CONCENTRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Atlantis Consumer Healthcare, Inc.. The most commonly reported adverse reactions for STANDARDIZED SENNA CONCENTRATE include FATIGUE, CONSTIPATION, PAIN, HEADACHE, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for STANDARDIZED SENNA CONCENTRATE.
Out of 12,237 classified reports for STANDARDIZED SENNA CONCENTRATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 46,972 FDA FAERS reports that mention STANDARDIZED SENNA CONCENTRATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FATIGUE, CONSTIPATION, PAIN, HEADACHE, NAUSEA, OFF LABEL USE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Atlantis Consumer Healthcare, Inc. in connection with STANDARDIZED SENNA CONCENTRATE. Always verify the specific product and NDC with your pharmacist.